Cytosolic Carboxypeptidase 1 Loss in Bone Marrow Mesenchymal Stem Cells Inhibited Osteogenic Differentiation by Enhancing Microtubule Glutamylation
Cells Tissues Organs · 2025
DOI: 10.1159/000546259 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells Tissues Organs, 2025. Verfasst von Cancan Pan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Engineering Research Center of Tooth Restoration and Regeneration and Tongji Research Institute of Stomatology and Department of Oral Implan…. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Osteogenesis, Cell Differentiation, Microtubules. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 57 Literaturangaben.
Abstract (Originalsprache)
Introduction
Cytosolic carboxypeptidase 1 (CCP1) is a deglutamylase that antagonizes polyglutamylation. Mutations in human CCP1 gene cause a severe disease known as childhood-onset neurodegeneration with cerebellar atrophy (CONDCA), which is characterized by marked growth retardation. However, the role and mechanisms of CCP1 in skeletal development remain unclear.
Methods
In this study, we used CCP1 knockout (CCP1-KO) mice to assess bone mass changes by micro-CT, HE, alkaline phosphatase (ALP) staining, tartrate-resistant acid phosphatase staining and immunofluorescence staining. Changes in osteogenic differentiation, proliferation, and migration capacity of bone marrow mesenchymal stem cells (BMSCs) were assessed by ALP, alizarin red (ARS) staining, quantitative real-time PCR, EdU staining, and cell scratching assay. Then, tubulin glutamylation and primary cilia of BMSCs after deletion of CCP1 was analyzed by Western blot and immunofluorescence staining. Finally, CB839, an inhibitor of glutamine metabolism, was used to detect changes in the osteogenic differentiation ability and primary cilia of BMSCs after reducing the elevated glutamylation level.
Results
CCP1-KO mice exhibited phenotypes relevant to humans, including reduced body size, decreased bone mass, and reduced bone density during growth and development. CCP1 deficiency impairs the proliferation, migration, and osteogenic differentiation of BMSCs. Meanwhile, the number of pre-osteoblasts derived from BMSCs is decreased, leading to impaired osteogenesis. At the cellular level, CCP1 loss results in aberrant tubulin glutamylation, increased microtubule glutamylation, and shortened primary cilia in BMSCs. Finally, reduction of abnormally elevated tubulin glutamylation was efficacious for promoting osteogenic differentiation of BMSCs and restoring primary cilia length of BMSCs.
Conclusion
We propose that CCP1 plays a critical role in regulating BMSCs differentiation and promotes osteogenesis by modulating the post-translational modifications of tubulin, with a view to provide new targets for the prevention and treatment of hard tissue diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shanghai Engineering Research Center of Tooth Restoration and Regeneration and Tongji Research Institute of Stomatology and Department of Oral Implantology, Shanghai Tongji Stomatological Hospital and Dental School, Ton…
- School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China, huiyuan.wu@tju.edu.cn.
Zitieren
APA
Pan, C., Gong, X., Wang, X., Wu, H., & Sun, Y. (2025). Cytosolic Carboxypeptidase 1 Loss in Bone Marrow Mesenchymal Stem Cells Inhibited Osteogenic Differentiation by Enhancing Microtubule Glutamylation. Cells Tissues Organs. https://doi.org/10.1159/000546259
Vancouver
Pan C, Gong X, Wang X, Wu H, Sun Y. Cytosolic Carboxypeptidase 1 Loss in Bone Marrow Mesenchymal Stem Cells Inhibited Osteogenic Differentiation by Enhancing Microtubule Glutamylation. Cells Tissues Organs. 2025. doi:10.1159/000546259
BibTeX
@article{Pan2025,
author = {Pan, Cancan and Gong, Xuyan and Wang, Xuekui and Wu, Huiyuan and Sun, Yao},
title = {Cytosolic Carboxypeptidase 1 Loss in Bone Marrow Mesenchymal Stem Cells Inhibited Osteogenic Differentiation by Enhancing Microtubule Glutamylation},
journal = {Cells Tissues Organs},
year = {2025},
doi = {10.1159/000546259}
}
EUVIMED